HHS announces standard definition for opioid withdrawal in infants

Feb 01, 2022 - 11:58 AM
HHS Logo web sized 900x400

The Department of Health and Human Services yesterday announced a standard clinical definition for opioid withdrawal in infants. Recently published in the Journal of Pediatrics, the definition includes prenatal exposure and at least two of the most common clinical signs of withdrawal (excessive crying, fragmented sleep, tremors, increased muscle tone or gastrointestinal dysfunction). 

“As a pediatrician, I have seen the need for a standard clinical definition for opioid withdrawal in neonates, and am excited to see this step in improving care for infants and their families as part of the HHS Overdose Prevention Strategy,” said HHS Assistant Secretary for Health ADM Rachel Levine. “I look forward to working across all health sectors to get this definition adopted into clinical practice.”
 

Related News Articles

Headline
FDA advances new recommendations on overdose prevention, considers over-the-counter Narcan
The Food and Drug Administration yesterday issued a report offering recommendations to address the opioid crisis and the role of analgesic oversight in…
Headline
FDA: Bebtelovimab not expected to neutralize certain omicron subvariants; naloxone may not reverse certain illicit opioids
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected…
Headline
CDC updates opioid prescribing guidelines for clinicians
The Centers for Disease Control and Prevention today released updated guidelines for clinicians prescribing opioids to outpatients for short- or long-term…
Headline
AHA Podcast: Mastering opioid stewardship deployment
In this episode – part four of AHA’s five-part series on opioid stewardship – Marie Cleary-Fishman, AHA’s vice president of clinical quality, is joined once…
Headline
Podcast: Opioid stewardship program construction 101
In part three of AHA’s five-part series on opioid stewardship, Marie Cleary-Fishman, AHA’s vice president of clinical quality, speaks with Holly Geyer, M.D.,…
Headline
HRSA announces grants to expand rural access to opioid use disorder treatment
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in…